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1. Introduction 
2. Clinical  
3.Results  
 
Within the 2008 World Health Organization classification (WHO), Polycythemia Vera (PV), Essential Thrombocythemia (ET) and Primary Myelofibrosis (PMF) belong to the 












































JAK2V617F coexisting with CALR mutation in ET 
 
CALR mutation in JAK2-negative PV 
 
Two cases of atypical CALR mutations in MPN patients 
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Patient 1 
Age, y 62 
Sexe, M/F M 
Hemoglobin (g/dL) 17.8  
Hematocrit (%) 58 
Platelets (g/L) 466 
EPO  (mUI/mL) 8.7 












MPL mutation Negative 
BCR-ABL1 Negative 
CALR mutation Positive 
4.Conclusion  






CALR mutation in JAK2-negative PV 


























JAK2-V617F coexisting with CALR mutation in ET 


























 Major Criteria  if Hb > 18.5 g/dL 
WHO Criteria- Essential Thrombocythemia 
4 Criteria 
Patient 2 
Age, y 44 
Sexe, M/F M 
Hemoglobin (g/dL) 14.1 
Hematocrit (%) 40.3 











MPL mutation Negative 
BCR-ABL1 Negative 







ET carrying both CALR and JAK2-V617F mutations 
 JAK2-V617F can coexisting with CALR mutations in rare ET/PMF cases 
( McGaffin G. et al, 2014; Lim K.H. et al, 2015) 
The majority of PV carries a JAK2-V617F mutation 
 (JAK2V617F).  
The recently described calreticulin (CALR) mutations are preferentially associated with 
 JAK2-V617F-negative and Myeloproliferative Leukemia Virus Oncogene (MPL) mutations negative ET 
or PMF. (Cross N.C., 2011).  
JAK2-V617F/exon12-negative presumptive PV with a CALR mutation 
However, retrospective studies recently revealed that:  
Here, we describe TWO of such atypical cases: 
 
CALR mutations could be detected in JAK2-negative PV.  




WHO Criteria-Polycythemia Vera 
         2 Major Criteria +1 Minor Criteria 
    or  First Major Criteria + 2 Minor Criteria 
 Major Criteria  if Hct increased 
 Minor Criteria  if Subnormal 
Evocative of  a PV 
 Platelets count >450x10⁹/L 
 Megakaryocyte proliferation/No PMF 
 Demonstration of JAK2-V617F 
 No PV 
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